December 1, 2004
APPLICATION FOR
LICENCE FOR INTENTIONAL RELEASE OF GMOs INTO THE ENVIRONMENT:
Application No. DIR 057/2004
This
document in PDF format:
DIR 057/2004 - Brassica juncea licence application
summary
SUMMARY INFORMATION
Project
Title: |
Field trials of genetically modified
herbicide tolerant, hybrid Brassica juncea |
Applicant: |
Bayer CropScience Pty Ltd
391-393 Tooronga Road
East Hawthorn VIC 3123 |
Common name of the parent organism: |
Indian
mustard (includes Brown and Oriental mustard) |
Scientific name of the parent
organism: |
Brassica juncea (L.) Czern
and Coss. |
Modified trait(s): |
Herbicide tolerance and hybrid breeding system |
Identity of the gene(s) responsible for the modified
trait(s):
|
A
hybrid breeding system consisting of the barnase
(male sterility) and barstar (fertility restorer)
genes derived from the bacterium
Bacillus amyloliquefaciens and a herbicide tolerance
gene.
(Details of the herbicide tolerance gene, gene
constructs including the plasmid maps, identity and
precise arrangements of the regulatory sequences and the
molecular characterisation data have been declared as
Confidential Commercial Information. However the CCI
will be made available to the various prescribed expert
authorities that will be consulted on the preparation of
the risk assessment and risk management plan.) |
Proposed Location(s) |
Shires for Winter trials
(2005-2008):
New
South Wales: Coolamon,
Culcairn, Lockhart, Junee, Wagga Wagga and Narrandera
South Australia:
Naracoorte/Lucindale, Grant, Wattle Range
Victoria: Ararat,
Hindmarsh, Glenelg, Horsham, Moyne, Northern Grampians,
Southern Grampians and Yarriambiack
Shires for Summer trials (2005-2008):
South Australia: Grant,
Naracoorte/Lucindale and Wattle Range
Victoria:
Glenelg, Moyne, Northern Grampians and Southern
Grampians |
Proposed Release Size: |
Maximum area of 4 hectares/site at 4
sites each in the winter and summer growing seasons. |
Proposed Release Dates: |
May 2005 to May 2008 |
Introduction
The Gene
Technology Act 2000 (the Act) took effect on 21 June 2001.
The Act, supported by the Gene Technology Regulations 2001,
an inter-governmental agreement and corresponding legislation
that is being enacted in each State and Territory, underpins
Australia’s nationally consistent regulatory system for gene
technology. Its objective is to protect the health and safety of
people, and the environment, by identifying risks posed by or as
a result of gene technology, and managing those risks by
regulating certain dealings with genetically modified organisms
(GMOs).
The Act
establishes a statutory officer, the Gene Technology Regulator
(the Regulator), to administer the legislation and make
decisions under the legislation. The
Regulator is supported by the Office of the Gene Technology
Regulator (OGTR), an Australian Government regulatory agency
located within the Health and Ageing portfolio.
The legislation
sets out the requirements for considering applications for
licences for dealings with GMOs and the matters that the
Regulator must take into account before deciding whether, or
not, to issue a licence.
The
application and the proposed dealings
The OGTR has
received an application from Bayer CropScience Pty Ltd (Bayer)
for a licence for the intentional release of genetically
modified (GM) Brassica juncea (Indian mustard) into the
environment on a limited scale and under controlled conditions.
The GM B. juncea lines proposed for release have been
genetically modified by the introduction of genes for herbicide
tolerance and hybrid breeding system based upon seed production
(male sterility (MS)/fertility restorer (RF) lines see section
below on Genetic Modification)j.
The main aims of the proposed trials are to
evaluate the effectiveness of the herbicide tolerance trait in
the field, to observe the agronomic performance of the GM B.
juncea lines and to increase seed.
Herbicide tolerant, hybrid seeds from GM
B. juncea lines would be collected and used for future
developmental work in Australia (subject to further approvals)
and shipped to Canada for further trait evaluation. Bayer
envisages that seeds from promising lines identified in Canada
may be returned for evaluation in subsequent seasons in
Australia.
Bayer also
proposes to compare the agronomic performance of B. juncea
with the GM herbicide tolerant, hybrid canola (B. napus),
approved for a limited and controlled release under Licence No.
DIR032/2003 (this would require a variation to the existing
licence), GM herbicide tolerant, hybrid InVigor®
canola approved under Licence No. DIR021/2001 for commercial
release, and conventional canola varieties.
Bayer plans to
conduct the field trials at 4 sites in the winter and summer
growing seasons of 2005-2008 on a maximum of 4 hectares per
site. A total of 17 shires in New South Wales, South Australia
and Victoria have been chosen as potential locations for these
trials.
Since the
research is at a preliminary stage and information on the novel
gene constructs is still limited, the applicant has proposed a
range of containment measures to restrict the spread and
persistence of the genetic material for the GM B. juncea
in the environment.
None of the GM
B. juncea plants from the release, or their by-products
would be used for stock feed or human food. An approval from
FSANZ would be required before oil from the GM B. juncea
lines could be used for human consumption.
The APVMA is
responsible for the use and safety of herbicides in Australia.
A research permit from the APVMA for use of the herbicide in the
trial may be required for the proposed field trials.
Confidential Commercial Information
Bayer has sought and received approval to
have details of the herbicide tolerance gene, gene constructs
including the plasmid maps, precise arrangements of the
regulatory sequences and data on molecular characterisation as
Confidential Commercial Information (CCI) under section 185 of
the Act. However, the CCI will be made available to the
prescribed expert groups and agencies that will be consulted on
the preparation of the risk assessment and risk management plan
for this application.
Previous
releases of the GMO
There has been
no previous release of the proposed GM herbicide tolerant,
hybrid B. juncea in Australia. However the Regulator
issued a licence to Bayer in March 2004 for a limited and
controlled release of GM canola (B. napus) containing the
same herbicide tolerance and hybrid traits (Licence No.
DIR032/2002). The Regulator has also approved releases of:
·
InVigorÒ
GM canola lines that contained the same hybrid breeding system
as the GMO proposed for release but modified to be tolerant to a
different herbicide (glufosinate ammonium) for trial under
limited and controlled conditions (Licence No. DIR 010/2001 on
30 July 2002) and for commercial release under Licence No.
DIR021/2001 on 25 July 2003; and
·
Roundup ReadyÒ
GM canola lines tolerant to the herbicide glyphosate for trial
under limited and controlled conditions (Licence No. DIR011/2001
on 22 August 2002) and for commercial release under Licence No.
DIR020/2001 on 19 December 2003.
Under the
former voluntary system that was overseen by the Genetic
Manipulation Advisory Committee (GMAC) several field trials of
GM B. napus, B. rapa and B. juncea lines
were conducted that include the following Planned Releases (PRs)
and extensions to them:
·
PR60 - GM B. napus lines tolerant to herbicide
glufosinate ammonium;
·
PR62 - GM B. napus lines that contained the hybrid
breeding system and tolerance to the herbicide glufosinate
ammonium;
·
PR77 - GM B. napus lines tolerant to the
herbicide Roundup Ready®
;
·
PR85 - GM B. rapa lines that contained the hybrid
breeding system and tolerance to the herbicide glufosinate
ammonium; and
·
PR90 and PR93 - GM B. juncea lines that contained the
hybrid breeding system and tolerance to the herbicide
glufosinate ammonium.
There have been no reports of adverse effects
on human health or the environment resulting from any of these
releases.
Parent
organism
The parent organism B. juncea (L.)
Czern. and Coss., commonly known as ‘Indian,
Oriental or Brown Mustard’, belongs to the Cruciferae family (Brassicaceae).
In Australia the generic term ‘Indian mustard’ is used to
include both the Brown and the Oriental mustards. B. juncea
is closely related botanically to B. napus (canola) and
B. rapa (rapeseed, turnip) and has a similar growth
habit.
India and Canada produce the bulk of the
world’s mustard seed. India ranks first and accounts for around
80% of the 4-6 million hectares of oilseed production annually.
Canada is the second largest producer where it is predominantly
used for oilseed production. In Australia, B. juncea has
been grown for the past 25 years for cold pressed oil and as a
condiment for the spice market. B. juncea is generally
grown as a winter/spring crop, although it is grown as a summer
crop in some states, with major centres of production in western
Victoria and central New South Wales. However, the scale of
cultivation is very small compared to B. napus.
B. juncea has
been found to be more tolerant to heat and water stress than
B. napus, matures more quickly and produces seed pods that
are less prone to shatter. In addition, it exhibits enhanced
yield and biofumigation effects when used as a break crop prior
to growing wheat due to more effective suppression of cereal
root pathogens.
Interest in growing B. juncea as an
alternative to B. napus has recently increased in western
Canada and Australia since higher yielding, enhanced oil content
and low erucic acid and glucosinolate varieties are becoming
available through conventional breeding programs that aim to
develop “canola quality” (CQ) B. juncea cultivars. These
CQ B. juncea cultivars are expected to be demonstrated to
farmers in 2005 with commercial release anticipated in 2006.
Genetic
modification and its effect
The herbicide
tolerant, hybrid GM B. juncea lines contain a gene that
confers herbicide tolerance, and the barnase and
barstar genes that form the basis of a novel breeding system
which emulates the natural phenomenon of hybrid vigour. Both
the genes are derived from a common soil bacterium Bacillus
amyloliquefaciens.
Bayer’s system
involves crossing male sterile (MS) lines containing the
barnase gene with the fertility restorer (FS) lines
containing the barstar gene.
The barnase
gene encodes for the Barnase enzyme (a ribonuclease) expressed
at the early stage of anther development (the pollen-bearing
parts of the flower) in a specific cell layer of the anthers,
preventing pollen production and thus conferring male sterility.
Flower morphology of the selected male sterile line is
characterised by the absence of anthers.
Expression of
the barstar gene is also restricted to the anthers by the
use of an anther-specific promoter. In hybrid plants derived
from crosses of MS and RF lines, the protein expressed by the
barstar gene inhibits the Barnase enzyme enabling normal
anther development and pollen production. These hybrids are
therefore fully fertile.
The male
sterile and fertility restorer lines have also been genetically
modified to contain a herbicide tolerance gene. The herbicide
tolerance trait may be used for weed management in the GM B.
juncea crop.
Some
regulatory sequences transferred to the GM B. juncea
plants are derived from plant pathogens. However, they
represent only a very small proportion of the pathogen’s genome
and the sequences are not, in themselves, infectious or
pathogenic.
Method of genetic modification
The herbicide
tolerance gene, the MS gene (barnase) and the RF gene (barstar)
were introduced into B. napus lines on plasmid vectors
carried by Agrobacterium tumefaciens (a soil bacterium).
The plasmid vector is disarmed since it lacks the oncogenes that
encode the tumorigenic functions of A. tumefaciens. The
A. tumefaciens mediated transformation system is a
frequently employed plant transformation method used routinely
in many laboratories in Australia and overseas for introducing
new genes into plants without causing any biosafety problems.
Consultation on preparation of the Risk Assessment and Risk
Management Plan
The Regulator has made an initial assessment
as to whether the proposed release may pose significant risks to
human health and safety or the environment, in accordance with
section 49 of the Act. Due to the low risk potential of the
GMO, the control measures that will be imposed, and the limited
scale and scope of the dealings, the Regulator has decided
that the proposed release does not pose a significant risk to
human health and safety or the environment.
This means that the Regulator is not
required to seek public comment on the assessment of this
proposal until after a risk assessment and risk management plan
(RARMP) has been prepared. In the interim, copies of the
application are available on request from the OGTR. Please
quote application number DIR 057/2004.
In preparing the RARMP, the Regulator will
seek input from a wide range of key stakeholders and expert
groups including State and Territory Governments, relevant
Australian Government agencies, the Minister for the Environment
and Heritage, panel of experts and appropriate local councils.
The Regulator will again consult with these prescribed agencies
and authorities as well as the public in finalising the RARMP,
as required by the Act.
At this stage, the
consultation version of the
RARMP is expected to be released for an extended
six week consultation period in late February 2005.
The public will be invited to provide submissions on the
RARMP via advertisements in the media and direct mail to anyone
registered on the OGTR mailing list. Summaries and copies of
the RARMP will be available from the OGTR, or on the OGTR
website.
If you have any questions about the
application or the assessment process, please contact the OGTR
at:
The Office of the Gene Technology Regulator
MDP 54
PO Box 100
WODEN ACT 2606
Tel: 1800 181 030
Fax: 02 6271 4202
Email:
ogtr@health.gov.au
Website
www.ogtr.gov.au
RELATED DOCUMENTS
Early-bird notification: Your chance to comment on the Risk
Assessment and Risk Management Plan for dealings involving
intentional release of genetically modified Brassica juncea
: DIR 057/2004- posted 1 December 2004 (PDF format)
Questions &
Answers on Licence Application DIR 057/2004 for Limited and
Controlled Release of Genetically Modified Brassica juncea
(Indian Mustard)
(PDF
format) |